FDA
See what's moving around FDA and get a calibrated, source-checked read on what happens next — and where it diverges from the market.
Markets pricing FDA now
FDA approves Outlook Therapeutics' ONS-5010?
87% Yes
FDA approves Sanofi's Subcutaneous Sarclisa?
89% Yes
FDA approves Viatris' low-dose estrogen weekly patch?
88% Yes
Prediction-market prices — a signal of what the crowd believes, not our read. Ask for the calibrated take.